Cargando…
Fidaxomicin Use for Clostridium Difficile Infection Probably Decreases the Effect of Coumadin® in Elderly
The incidence of Clostridium difficile infection (CDI) has been decreasing in the last decade, though the incidence of community-acquired CDI has remained stable. In an elderly patient on Coumadin®, we report an unexpected decrease in international normalized ratio (INR) during the treatment of seco...
Autores principales: | Dhruv, Samyak, Polavarapu, Abhishek, Gumaste, Vivek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785468/ https://www.ncbi.nlm.nih.gov/pubmed/33425501 http://dx.doi.org/10.7759/cureus.11915 |
Ejemplares similares
-
Fidaxomicin as a Salvage Therapy for Fulminant Clostridioides difficile Infection
por: Heleno, Caio T, et al.
Publicado: (2021) -
Fidaxomicin vs Vancomycin for the Treatment of a First Episode of Clostridium Difficile Infection: A Meta-analysis and Systematic Review
por: Al Momani, Laith A, et al.
Publicado: (2018) -
Gastric Carcinoid: The Invisible Tumor!
por: Dhruv, Samyak, et al.
Publicado: (2021) -
Sister Mary Joseph’s Nodule: Where Umbilicus Holds the Truth!
por: Dhruv, Samyak, et al.
Publicado: (2021) -
Fidaxomicin - the new drug for Clostridium difficile infection
por: Vaishnavi, Chetana
Publicado: (2015)